This is the line I was looking for. Not that I know how protease inhibitor works, but looks more like a traditional anti-viral approach v.s. the potentially DNA altering molnupiravir.
This is the line I was looking for. Not that I know how protease inhibitor works, but looks more like a traditional anti-viral approach v.s. the potentially DNA altering molnupiravir.
The UK scientific advisory group SAGE published a few months ago that combination therapy might be useful to avoid 'antiviral resistant' strains of SARS cov-2 evolving. Perhaps these 3cl protease inhibitors may be used in combination.
When I first read about molnupiravir's mode of action, my gut reaction was "cancer in a pill, no thanks"
https://www.ema.europa.eu/en/news/covid-19-ema-starts-rollin...
Calling out the OP for being wrong and them admitting they have no knowledge in the area is not an ad hominem attack.
The OPs theory was disproven on its merits alone.